Literature DB >> 22346442

Microbiological processing of respiratory specimens from patients with cystic fibrosis.

.   

Abstract

Entities:  

Year:  1993        PMID： 22346442      PMCID： PMC3250786          DOI： 10.1155/1993/989086

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  9 in total

1.  Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media.

Authors:  M Maduri-Traczewski; C L'Heureux; L Escalona; A Macone; D Goldmann
Journal:  Diagn Microbiol Infect Dis       Date:  1986-11       Impact factor: 2.803

Review 2.  Cystic fibrosis: a review of pulmonary infections and interventions.

Authors:  M J Thomassen; C A Demko; C F Doershuk
Journal:  Pediatr Pulmonol       Date:  1987 Sep-Oct

3.  Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis.

Authors:  M J Thomassen; J D Klinger; S J Badger; D W van Heeckeren; R C Stern
Journal:  J Pediatr       Date:  1984-03       Impact factor: 4.406

4.  Selective media for the quantitation of bacteria in cystic fibrosis sputum.

Authors:  K Wong; M C Roberts; L Owens; M Fife; A L Smith
Journal:  J Med Microbiol       Date:  1984-04       Impact factor: 2.472

5.  Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; L M Bradshaw; D V Schidlow; B T DeCicco
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

6.  Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.

Authors:  L A Carson; O C Tablan; L B Cusick; W R Jarvis; M S Favero; L A Bland
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

7.  Bacteriology of the maxillary sinuses in patients with cystic fibrosis.

Authors:  E D Shapiro; G J Milmoe; E R Wald; J B Rodnan; A D Bowen
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

8.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

9.  Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.

Authors:  M R Hammerschlag; L Harding; A Macone; A L Smith; D A Goldmann
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948
  9 in total
  5 in total

1.  Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.

Authors:  Juyan Zhou; Elizabeth Garber; Manisha Desai; Lisa Saiman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  The novel complex allele [A238V;F508del] of the CFTR gene: clinical phenotype and possible implications for cystic fibrosis etiological therapies.

Authors:  Anna Diana; Angela Maria Polizzi; Teresa Santostasi; Luigi Ratclif; Maria Giuseppina Pantaleo; Giuseppina Leonetti; Danila Rosa Iusco; Crescenzio Gallo; Massimo Conese; Antonio Manca
Journal:  J Hum Genet       Date:  2016-02-25       Impact factor: 3.172

3.  Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis.

Authors:  M R Shreve; S Butler; H J Kaplowitz; H R Rabin; D Stokes; M Light; W E Regelmann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.

Authors:  Samantha J Thulborn; Madiha Dilpazir; Koirobi Haldar; Vijay Mistry; Christopher E Brightling; Michael R Barer; Mona Bafadhel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-18

Review 5.  Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract.

Authors:  Megan R Kiedrowski; Jennifer M Bomberger
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.